Symptoms of Depression in Adults
Depression is characterized by depressed mood or loss of interest/pleasure (anhedonia) along with at least 5 total symptoms lasting at least 2 weeks that impair normal functioning. 1
Core Diagnostic Symptoms
The two cardinal symptoms that define depression are:
- Depressed mood - feeling down, sad, or hopeless most of the day, nearly every day 2, 1
- Anhedonia - markedly diminished interest or pleasure in activities that were previously enjoyable 2, 1
At least one of these two core symptoms must be present for diagnosis. 1
Additional Diagnostic Symptoms
To meet diagnostic criteria, at least 5 total symptoms (including one of the core symptoms above) must be present during the same 2-week period:
- Sleep disturbances - insomnia or hypersomnia nearly every day 2, 1
- Fatigue or loss of energy - persistent tiredness even without exertion 2, 1
- Appetite changes - significant weight loss/gain or changes in appetite 2
- Low self-view - feelings of worthlessness or excessive/inappropriate guilt 2
- Concentration difficulties - diminished ability to think, concentrate, or make decisions 2
- Psychomotor changes - agitation or retardation observable by others 2, 1
- Thoughts of self-harm - recurrent thoughts of death or suicidal ideation 2
Severity Assessment
Depression severity is classified based on symptom count, intensity, and functional impairment:
- Mild depression: PHQ-9 score 5-9 or minimal functional impairment 2, 1
- Moderate depression: PHQ-9 score 10-14 or moderate functional impairment 2, 1
- Severe depression: PHQ-9 score 15-27 or marked functional impairment 2, 1
Screening Tools
The PHQ-9 is the recommended validated screening tool, starting with the 2-item version asking about depressed mood and anhedonia. 2, 1
- If the 2-item PHQ score is 0-1, no further screening is needed 2
- If the 2-item PHQ score is 2-3, complete the full 9-item questionnaire 2
- Alternative validated tools include the Hamilton Depression Rating Scale (HAM-D) and Hospital Anxiety and Depression Scale (HADS) 2
Critical Red Flags Requiring Emergency Evaluation
Any patient expressing suicidal ideation or risk of harm to self/others requires immediate referral for emergency psychiatric evaluation. 2, 3
- Suicidal thinking and behavior risk is highest in the first few months of antidepressant treatment, particularly in patients under age 24 3
- Emergence of agitation, panic attacks, severe insomnia, irritability, hostility, or impulsivity may represent precursors to suicidality 3
Common Comorbidities to Assess
- Anxiety disorders: 50-60% of patients with depression have comorbid anxiety, most commonly generalized anxiety disorder 2
- Substance use disorders: Common in untreated depression and worsen prognosis 1
- Bipolar disorder screening: Essential before initiating antidepressants, as treating unrecognized bipolar depression with antidepressants alone may precipitate manic episodes 3
Treatment Options
First-Line Treatments
Either cognitive behavioral therapy (CBT) or second-generation antidepressants (SSRIs/SNRIs) are equally effective first-line treatments for moderate depression. 1, 4
- For mild depression, start with CBT alone 1
- For moderate to severe depression, initiate either CBT or antidepressants based on patient preference, cost, and side effect concerns 1
- For severe depression, combination therapy (CBT + antidepressant) is superior to monotherapy, nearly doubling remission rates (57.5% vs 31.0%) 1, 4
Pharmacotherapy Specifics
- SSRIs (fluoxetine, escitalopram, citalopram) or SNRIs (venlafaxine, duloxetine) are first-line medications 1
- SNRIs are slightly more effective than SSRIs but have higher rates of nausea and vomiting 1
- Selection should be based on adverse effect profiles, drug interactions, prior treatment response, and patient preference 2
- Therapeutic effects typically require 4-6 weeks at adequate doses 1
Psychotherapy Options
Effective psychotherapy modalities include:
- Cognitive behavioral therapy (CBT) 1, 4
- Behavioral activation 4
- Interpersonal therapy (IPT) 4
- Problem-solving therapy 4
- Brief psychodynamic therapy 4
Treatment Duration
- Continue treatment for at least 4-9 months after satisfactory response for first episodes 1
- For recurrent depression, continue treatment for ≥1 year or longer 1
- Premature discontinuation is a common pitfall leading to relapse 1
Monitoring and Follow-Up
- Assess treatment response within 1-2 weeks of initiation, monitoring for therapeutic effects, adverse effects, and suicidality 1
- If inadequate response by 6-8 weeks, modify treatment through dose adjustment, medication switching, or augmentation strategies 1
- Close monitoring significantly improves treatment success, with collaborative care programs showing substantial symptom improvement (SMD 0.42) compared to usual care 4
Special Considerations
Medical Causes
Always first treat underlying medical causes of depressive symptoms (unrelieved pain, fatigue) and delirium (infection, electrolyte imbalance) before attributing symptoms to primary depression. 2, 5
Marital/Relationship Issues
When depression occurs with significant marital distress, behavioral couples therapy should be added to individual CBT 6